Literature DB >> 22740692

Glutamate binding to the GluN2B subunit controls surface trafficking of N-methyl-D-aspartate (NMDA) receptors.

Kevin She1, Joana S Ferreira, Ana Luisa Carvalho, Ann Marie Craig.   

Abstract

Trafficking of NMDA receptors to the surface of neurons and to synapses is critical for proper brain function and activity-dependent plasticity. Recent evidence suggests that surface trafficking of other ionotropic glutamate receptors requires ligand binding for exit from the endoplasmic reticulum. Here, we show that glutamate binding to GluN2 is required for trafficking of NMDA receptors to the cell surface. We expressed a panel of GluN2B ligand binding mutants in heterologous cells with GluN1 or in rat cultured neurons and found that surface expression correlates with glutamate efficacy. Such a correlation was found even in the presence of dominant negative dynamin to inhibit endocytosis and surface expression correlated with Golgi localization, indicating differences in forward trafficking. Co-expression of wild type GluN2B did not enhance surface expression of the mutants, suggesting that glutamate must bind to both GluN2 subunits in a tetramer and that surface expression is limited by the least avid of the two glutamate binding sites. Surface trafficking of a constitutively closed cleft GluN2B was indistinguishable from that of wild type, suggesting that glutamate concentrations are typically not limiting for forward trafficking. YFP-GluN2B expressed in hippocampal neurons from GluN2B(-/-) mice rescued synaptic accumulation at similar levels to wild type. Under these conditions, surface synaptic accumulation of YFP-GluN2B mutants also correlated with apparent glutamate affinity. Altogether, these results indicate that glutamate controls forward trafficking of NMDA receptors to the cell surface and to synapses and raise the intriguing idea that NMDA receptors may be functional at intracellular sites.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22740692      PMCID: PMC3431666          DOI: 10.1074/jbc.M112.345108

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  cAMP-dependent protein kinase mediates activity-regulated synaptic targeting of NMDA receptors.

Authors:  F T Crump; K S Dillman; A M Craig
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

2.  Distribution, density, and clustering of functional glutamate receptors before and after synaptogenesis in hippocampal neurons.

Authors:  J R Cottrell; G R Dubé; C Egles; G Liu
Journal:  J Neurophysiol       Date:  2000-09       Impact factor: 2.714

3.  Export from the endoplasmic reticulum of assembled N-methyl-d-aspartic acid receptors is controlled by a motif in the c terminus of the NR2 subunit.

Authors:  Lynda M Hawkins; Kate Prybylowski; Kai Chang; Caroline Moussan; F Anne Stephenson; Robert J Wenthold
Journal:  J Biol Chem       Date:  2004-04-21       Impact factor: 5.157

4.  Activity and protein kinase C regulate synaptic accumulation of N-methyl-D-aspartate (NMDA) receptors independently of GluN1 splice variant.

Authors:  Joana S Ferreira; Amanda Rooyakkers; Kevin She; Luis Ribeiro; Ana Luísa Carvalho; Ann Marie Craig
Journal:  J Biol Chem       Date:  2011-06-15       Impact factor: 5.157

5.  The distribution of glycine, GABA, glutamate and aspartate in rabbit spinal cord, cerebellum and hippocampus.

Authors:  S J Berger; J C Carter; O H Lowry
Journal:  J Neurochem       Date:  1977-01       Impact factor: 5.372

6.  Casein kinase 2 regulates the NR2 subunit composition of synaptic NMDA receptors.

Authors:  Antonio Sanz-Clemente; Jose A Matta; John T R Isaac; Katherine W Roche
Journal:  Neuron       Date:  2010-09-23       Impact factor: 17.173

7.  Ligand-binding domain determines endoplasmic reticulum exit of AMPA receptors.

Authors:  Sarah K Coleman; Tommi Möykkynen; Sami Hinkkuri; Lauri Vaahtera; Esa R Korpi; Olli T Pentikäinen; Kari Keinänen
Journal:  J Biol Chem       Date:  2010-09-13       Impact factor: 5.157

8.  EphB controls NMDA receptor function and synaptic targeting in a subunit-specific manner.

Authors:  Mark J Nolt; Ying Lin; Martin Hruska; Jessica Murphy; Sean I Sheffler-Colins; Matthew S Kayser; Joel Passer; Michael V L Bennett; R Suzanne Zukin; Matthew B Dalva
Journal:  J Neurosci       Date:  2011-04-06       Impact factor: 6.167

9.  Molecular determinants controlling NMDA receptor synaptic incorporation.

Authors:  Granville P Storey; Ximena Opitz-Araya; Andres Barria
Journal:  J Neurosci       Date:  2011-04-27       Impact factor: 6.167

10.  A functional link between dynamin and the actin cytoskeleton at podosomes.

Authors:  G C Ochoa; V I Slepnev; L Neff; N Ringstad; K Takei; L Daniell; W Kim; H Cao; M McNiven; R Baron; P De Camilli
Journal:  J Cell Biol       Date:  2000-07-24       Impact factor: 10.539

View more
  17 in total

1.  Two N-glycosylation Sites in the GluN1 Subunit Are Essential for Releasing N-methyl-d-aspartate (NMDA) Receptors from the Endoplasmic Reticulum.

Authors:  Katarina Lichnerova; Martina Kaniakova; Seung Pyo Park; Kristyna Skrenkova; Ya-Xian Wang; Ronald S Petralia; Young Ho Suh; Martin Horak
Journal:  J Biol Chem       Date:  2015-06-04       Impact factor: 5.157

2.  Mechanistic Insight into NMDA Receptor Dysregulation by Rare Variants in the GluN2A and GluN2B Agonist Binding Domains.

Authors:  Sharon A Swanger; Wenjuan Chen; Gordon Wells; Pieter B Burger; Anel Tankovic; Subhrajit Bhattacharya; Katie L Strong; Chun Hu; Hirofumi Kusumoto; Jing Zhang; David R Adams; John J Millichap; Slavé Petrovski; Stephen F Traynelis; Hongjie Yuan
Journal:  Am J Hum Genet       Date:  2016-11-10       Impact factor: 11.025

3.  Synaptic Dysfunction by Mutations in GRIN2B: Influence of Triheteromeric NMDA Receptors on Gain-of-Function and Loss-of-Function Mutant Classification.

Authors:  Marwa Elmasri; James S Lotti; Wajeeha Aziz; Oliver G Steele; Eirini Karachaliou; Kenji Sakimura; Kasper B Hansen; Andrew C Penn
Journal:  Brain Sci       Date:  2022-06-15

Review 4.  Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels.

Authors:  Kasper B Hansen; Lonnie P Wollmuth; Derek Bowie; Hiro Furukawa; Frank S Menniti; Alexander I Sobolevsky; Geoffrey T Swanson; Sharon A Swanger; Ingo H Greger; Terunaga Nakagawa; Chris J McBain; Vasanthi Jayaraman; Chian-Ming Low; Mark L Dell'Acqua; Jeffrey S Diamond; Chad R Camp; Riley E Perszyk; Hongjie Yuan; Stephen F Traynelis
Journal:  Pharmacol Rev       Date:  2021-10       Impact factor: 18.923

Review 5.  Pharmacological chaperoning: a primer on mechanism and pharmacology.

Authors:  Nancy J Leidenheimer; Katelyn G Ryder
Journal:  Pharmacol Res       Date:  2014-02-14       Impact factor: 7.658

6.  Nuclear respiratory factor 2 regulates the expression of the same NMDA receptor subunit genes as NRF-1: both factors act by a concurrent and parallel mechanism to couple energy metabolism and synaptic transmission.

Authors:  Anusha Priya; Kaid Johar; Margaret T T Wong-Riley
Journal:  Biochim Biophys Acta       Date:  2012-10-23

7.  HIV-1 protein Tat produces biphasic changes in NMDA-evoked increases in intracellular Ca2+ concentration via activation of Src kinase and nitric oxide signaling pathways.

Authors:  Kelly A Krogh; Nicole Wydeven; Kevin Wickman; Stanley A Thayer
Journal:  J Neurochem       Date:  2014-04-19       Impact factor: 5.372

8.  Agonist binding to the GluK5 subunit is sufficient for functional surface expression of heteromeric GluK2/GluK5 kainate receptors.

Authors:  Janet L Fisher; Paul R Housley
Journal:  Cell Mol Neurobiol       Date:  2013-08-23       Impact factor: 5.046

Review 9.  From bedside-to-bench: What disease-associated variants are teaching us about the NMDA receptor.

Authors:  Johansen B Amin; Gabrielle R Moody; Lonnie P Wollmuth
Journal:  J Physiol       Date:  2020-04-09       Impact factor: 5.182

Review 10.  Regulation of the NMDA receptor by its cytoplasmic domains: (How) is the tail wagging the dog?

Authors:  Yevheniia Ishchenko; Melissa G Carrizales; Anthony J Koleske
Journal:  Neuropharmacology       Date:  2021-06-20       Impact factor: 5.273

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.